Drew Amorosi

DAS28 were found to be significantly higher at baseline and at 12-month follow-up in a group of patients (n=9) with knee osteoarthritis.

The American College of Rheumatology holds mixed opinions on the proposed American Health Care Act.

Researchers have demonstrated that depression is a significant risk factor for progression from psoriasis to psoriatic arthritis.

The FDA has approved 26-week treatment efficacy claims for Zimmer Biomet’s knee osteoarthritis product.

There is little evidence to support the utility of biomarkers to guide clinical care for optimal RA treatment.

The Lupus Foundation of America announced it is accepting applications for 8 research grants to fund lupus research.

Dr Krant discussed some of the issues facing patients with RA.